15-Jan-2007 - Evotec Technologies GmbH

PerkinElmer Completes Acquisition of Euroscreen Products SA And Evotec Technologies

PerkinElmer, Inc. reported that it has successfully completed two previously announced acquisitions that will extend its portfolio of advanced tools for cellular analysis and High Content Screening (HCS). In the fourth quarter of 2006, the Company announced its intent to acquire Euroscreen Products S.A., the Gosselies, and Hamburg, Germany-based Evotec Technologies.

"The addition of Euroscreen Products' advanced GPCR technology and Evotec Technologies' highly regarded HCS systems to PerkinElmer's current portfolio enables us to offer our biopharma customers a comprehensive solution in advanced cellular imaging, screening and analysis," said Robert F. Friel, president, PerkinElmer Life and Analytical Sciences.

Ongoing revenue of the combined entities was approximately US$25 million in 2006, and both acquisitions are expected to be neutral to slightly accretive to the Company's 2007 earnings per share.

Facts, background information, dossiers
  • PerkinElmer
  • Evotec Technologies
  • Euroscreen
  • solution
  • cellular imaging
More about Evotec
  • News

    Evotec and Dow AgroSciences announce collaboration on Cellular Target Profiling

    Evotec AG announced that Evotec and Dow AgroSciences (DOW) have entered into a research collaboration with the objective of leveraging Evotec's chemical proteomics services to support compounds in development at Dow AgroSciences. To this end, Evotec will perform chemical proteomics services ... more

    Evotec to realign Discovery Chemistry Operations

    Evotec AG announced that it will close its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility, answering to an increasing requirement to operate closer to the principal R&D laboratories of our major customers. All project work in ... more

    Evotec AG announces multi-year agreement with The United States Environmental Protection Agency (EPA)

    Evotec AG announced that Evotec has entered into a multi-year compound management agreement with the United States EPA. The contract covers a period of five years and has a total value of up to EUR7.7 million (approx. USD 10 million).Under the agreement Evotec, through its San Francisco ope ... more

  • Companies

    Evotec SE

    Evotec is a leader in the discovery and development of novel small molecule drugs with operational sites in Europe and Asia. The Company has built substantial drug discovery expertise and an industrialised platform that can drive new innovative small molecule compounds into the clinic. In a ... more

More about PerkinElmer